EUVIMEDPoznaj EUVIMED
Open access · CC BY-NC-ND 4.0

Whole‐body MRI with diffusion‐weighted imaging as an adjunct to 18 F‐ fluorodeoxyglucose positron emission tomography and CT in patients with suspected recurrent colorectal cancer

Jeroen R J Willemse, Max J Lahaye, Niels F M Kok, Brechtje A Grotenhuis, Arend G J Aalbers, Geerard L Beets iD, Charlotte Rijsemus, Monique Maas, Larissa W van Golen, Regina G H Beets-Tan, Doenja M J Lambregts iD

Colorectal Disease · 2024

DOI: 10.1111/codi.16840 ↗

At a glance

Journal article in Colorectal Disease, 2024. Written by Jeroen R J Willemse and 10 co-authors. Institution: Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Major MEDLINE topics: Peritoneal Neoplasms, Colorectal Neoplasms. Cited 2 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Aim

The aim was to explore how findings of whole‐body MRI including diffusion‐weighted imaging (DW‐MRI) compared to the routine diagnostic workup with CT and/or 18 F‐fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT in patients with suspected recurrent colorectal cancer (CRC).

Method

This was an exploratory retrospective analysis of 55 patients with a clinical suspicion of recurrent CRC who underwent DW‐MRI following CT and/or FDG‐PET/CT. Two readers in consensus interpreted all clinical imaging reports and converted each described lesion into a confidence score (1 = definitely benign to 5 = definitely malignant). DW‐MRI findings were compared to the most recent previous CT or PET/CT. Any discrepant or additional DW‐MRI findings were documented and compared with histology and/or clinical follow‐up (if available).

Results

Whole‐body MRI including diffusion‐weighted imaging (DW‐MRI) resulted in discrepant/additional findings in 26/55 (47%) cases; 23/37 (62%) compared to previous CT and 3/18 (17%) compared to previous PET/CT. These included 10 cases where DW‐MRI converted previously inconclusive CT ( n = 8) or PET/CT ( n = 2) findings into a conclusive diagnosis, one where it contradicted a previous CT diagnosis of recurrence, five where DW‐MRI diagnosed recurrent disease not previously reported on CT and 10 cases where DW‐MRI detected additional lesions compared to CT ( n = 9) or PET/CT ( n = 1). Eighty‐eight per cent of cases with discrepant/additional findings concerned patients with recurrent/metachronous peritoneal metastases. In total, DW‐MRI resulted in 42 discrepant/additional lesions; the DW‐MRI diagnosis was correct in 76% of these lesions and incorrect (false positive) in 7%. In the remaining 17%, no standard of reference was available.

Conclusions

This explorative study suggests that DW‐MRI may be of added value to patients with a clinical suspicion for recurrent CRC, in particular to identify patients with peritoneal metastases. DW‐MRI mainly has potential as a ‘problem‐solver’ in patients with inconclusive or negative findings on previous imaging (in particular CT) and to detect additional disease sites in patients already diagnosed with recurrent disease.

Subjects

MeSH terms (MEDLINE)

Peritoneal NeoplasmsColorectal NeoplasmsHumansDiffusion Magnetic Resonance ImagingPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Retrospective StudiesMagnetic Resonance ImagingPositron-Emission TomographyRadiopharmaceuticals

Author keywords

Colorectal cancerDiffusion-weighted imagingPeritoneal carcinomatosisRecurrenceWhole-body MRI

Substances

Fluorodeoxyglucose F18Radiopharmaceuticals

Authors and institutions

  • Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.

ORCID profiles: Geerard L Beets, Doenja M J Lambregts

Cite

APA

Willemse, J. R. J., Lahaye, M. J., Kok, N. F. M., Grotenhuis, B. A., Aalbers, A. G. J., Beets, G. L., Rijsemus, C., Maas, M., van Golen, L. W., Beets-Tan, R. G. H., & Lambregts, D. M. J. (2024). Whole‐body MRI with diffusion‐weighted imaging as an adjunct to 18 F‐ fluorodeoxyglucose positron emission tomography and CT in patients with suspected recurrent colorectal cancer. Colorectal Disease. https://doi.org/10.1111/codi.16840

Vancouver

Willemse JRJ, Lahaye MJ, Kok NFM, Grotenhuis BA, Aalbers AGJ, Beets GL, et al. Whole‐body MRI with diffusion‐weighted imaging as an adjunct to 18 F‐ fluorodeoxyglucose positron emission tomography and CT in patients with suspected recurrent colorectal cancer. Colorectal Disease. 2024. doi:10.1111/codi.16840

BibTeX
@article{Willemse2024,
  author = {Willemse, Jeroen R J and Lahaye, Max J and Kok, Niels F M and Grotenhuis, Brechtje A and Aalbers, Arend G J and Beets, Geerard L and Rijsemus, Charlotte and Maas, Monique and van Golen, Larissa W and Beets-Tan, Regina G H and Lambregts, Doenja M J},
  title = {Whole‐body MRI with diffusion‐weighted imaging as an adjunct to 18 F‐ fluorodeoxyglucose positron emission tomography and CT in patients with suspected recurrent colorectal cancer},
  journal = {Colorectal Disease},
  year = {2024},
  doi = {10.1111/codi.16840}
}
Start for free →